Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”


HHS - 2619 - Tick-Borne Disease Working Group - Statutory (Congress Created)
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameTick-Borne Disease Working GroupAgency NameDepartment of Health and Human Services
Fiscal Year2022Committee Number2619
Original Establishment Date8/10/2017Committee StatusChartered
Actual Termination Date Committee URLhttps://www.hhs.gov/ash/advisory-committees/tic...
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*14
Current Charter Date8/10/2021Designated Fed Officer Position Title*Senior Advisor for Blood and Tissue Policy, Office of Infectious Disease and HIV/AIDS Policy
Date Of Renewal Charter8/10/2023Designated Federal Officer Prefix
Projected Termination Date12/13/2022Designated Federal Officer First Name*James
Exempt From Renewal*NoDesignated Federal Officer Middle NameJ
Specific Termination AuthoritySection 2062 of the 21st Century Cures ActDesignated Federal Officer Last Name*Berger
Establishment Authority*Statutory (Congress Created)Designated Federal Officer SuffixM.S., M.T.(ASCP), S.B.B.
Specific Establishment Authority*Section 2062 of the 21st Century Cures ActDesignated Federal Officer Phone*202 795-7608
Effective Date Of Authority*12/13/2016Designated Federal Officer Fax*202 692-2101
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*james.berger@hhs.gov
Committee Type*Continuing
Presidential*No
Committee Function*Scientific Technical Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Working Group is charged to review ongoing activities and research related to tick-borne diseases conducted by HHS and other federal agencies, identify gaps in research and advances made, and provide a report to Congress and the HHS Secretary on its finding and recommendations every two years. The Working Group is also charged with soliciting input from States, localities, and nongovernmental entities, including organizations representing patients, health care providers, researchers, and industry. Subcommittees established by the Working Group research topic areas determined relevant to its charge and provide reports, including action items, for discussion and consideration by the Working Group for the biannual reports. The 2020 Report was delivered to Congress and the HHS Secretary in January 2021 and also posted on the HHS website for public access. Five subcommittees with members representing a diversity of disciplines and views were formed in August 2021 to inform the next report due December 2022; at least two Working Group members co-chair each subcommittee. The Public Comment Subcommittee reviews public comments submitted to the Tick-Borne Disease mailbox and provides summary information to the Working Group to consider in developing their reports.
How is membership balanced?*The Working Group comprises 14 members - seven federal members and seven public members. Federal members are required to consist of one or more representatives from the following HHS organizational components: Office of the Assistant Secretary for Health, Centers for Disease Control and Prevention, Food and Drug Administration, National Institutes of Health, and such other agencies and offices of HHS and other individuals as the Secretary determines appropriate and beneficial to the functioning of the Working Group. Other federal members represent the Centers for Medicare and Medicaid Services, Department of Defense, and the United States Department of Agriculture. Public members are required to represent the following categories: physicians and other health care providers with experience in diagnosing and treating tick-borne diseases; scientists or researchers with expertise; patients and their family members; and members of nonprofit organizations that advocate for patients with respect to tick-borne diseases.
How frequent & relevant are cmte mtgs?*The Working Group is required to meet not less than two times a year. Three meetings were held in FY22 and focused on topics and issues that supported development of the 2022 report to the HHS Secretary and Congress, taking into consideration the 2018 and 2020 report.
Why advice can't be obtained elsewhere?*The 21st Century Cures Act (Public Law 114-255), Section 2062 Tick-Borne Diseases, authorized the HHS Secretary to establish a Tick-Borne Disease Working Group. In general, the Working Group is to provide expertise and to review all efforts within HHS related to all tick-borne diseases and examine agency research priorities in order to help ensure interagency coordination and minimize overlap. Every two years, the Working Group is required to submit a report to Congress and the HHS Secretary on its findings and any recommendations for improving the federal response to tick-borne diseases. The final report will be delivered to Congress in December of 2022.
Why close or partially close meetings?N/A
Recommendation Remarks
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*No
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationYes
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionYesAction CommentNot applicable
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentCost savings dependent on action taken on recommendationsGrants Review CommentNot Applicable
Number Of Recommendations*55Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThe 2018 Report to the HHS Secretary and Congress included 28 recommendations and the 2020 Report included 27 recommendationsAccess Agency WebsiteYes
% of Recs Fully Implemented*2.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentMany of the recommendations require long-term action which cannot be accomplished in a fiscal year.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*15.00%Access PublicationsYes
% of Recs Partially Implemented CommentMany of the recommendations require long-term action which cannot be accomplished in a fiscal year.Access OtherNo
Agency Feedback*Not ApplicableAccess CommentN/A
Agency Feedback Comment*HHS has the responsibility of ensuring the conduct of or support for epidemiological, basic, translational, and clinical research related to vector-borne diseases, including tick-borne diseases. Section 2062 of the 21st Century Cures Act mandated the Secretary of HHS establish the Tick-Borne Disease Working Group to review activities and research related to tick-borne diseases conducted by HHS and other federal agencies and provide a report to Congress and the HHS Secretary on its finding and recommendations every two years. Unless extended by Congress, the Working Group will be sunset in December 2022, six years after the date of enactment of the authorizing legislation.Narrative Description*
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$0.00Est Payments to Non-Fed Members Next FY*$0.00
Payments to Federal Members*$14,767.20Est. Payments to Fed Members Next FY*$10,337.04
Payments to Federal Staff*$206,405.39Estimated Payments to Federal Staff*$51,601.35
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$0.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$550,000.00Est. Other Costs Next FY*$150,019.00
Total Costs$771,172.59Est. Total Next FY*$211,957.39
Date Cost Last Modified11/8/2022 1:17 PMEst. Fed Staff Support Next FY*2.00
Federal Staff Support (FTE)*2.00Est Cost RemarksThe TBDWG is set to submit its final report to Congress and sunset in December 2022. This is reflected in the lower projected costs for FY23.
Cost Remarks  
Hide Section - Interest Areas

Interest Areas

Category
Area
Animals
Veterinary Medicine
Education
Education
Health
Health Care
Medical Education
Medical Practitioners
Public Health
Safety
Treatment
Medicine
Diseases
Illnesses
Medicine and Dentistry
Research
Research and Development
Veterans
Veterans and Veterans' Medical Care
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - SUBCOMMITTEES

SUBCOMMITTEES

Committee

Subcommittees

ActionCommittee System IDSubcommittee NameFiscal Year
 COM-039625Access to Care and Education2022
 COM-039626Changing Dynamics of Tick Ecology, Personal Protection and Control Subcommittee2022
 COM-039627Clinical Presentation and Pathogenesis2022
 COM-039619Diagnostics2022
 COM-039624Disease Prevention and Control2022
 COM-034984Public Comment2022
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-040533Tick-Borne Disease Working Group2021
 COM-038808Tick-Borne Disease Working Group2020
 COM-036690Tick-Borne Disease Working Group2019
 COM-034905Tick-Borne Disease Working Group2018
 COM-002040Tick-Borne Disease Working Group2017